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Review question(s)
To summarize current knowledge of the effectiveness of digital self-management support for adults with asthma
Searches
MEDLINE, EMBASE, CINAHL Plus, PsycINFO, ERIC, Cochrane Library (including CDSR, Cochrane Central
Register of Controlled Trials (CENTRAL), DARE, NHS EED, and HTA databases), DoPHER and TROPHI (both
produced by the EPPI Centre), Social Science Citation Index and Science Citation Index Expanded
Types of study to be included
We will consider only randomised controlled trials which have been published in peer reviewed journals where the
intervention is aimed at those with a diagnosis of Asthma as defined by the authors. These trials must:
(1) have randomised patients to an intervention and have a control group that is defined as usual care;
(2) have quantitative data on changes in outcomes;
(3) be of adults only (16+) or if including those below 16 years have data on those 16+ that can be extracted
separately;
(4) defined as a digital intervention;
(5) involve self- management by patients;
(6) only studies published in English.
Condition or domain being studied
Asthma is common, affecting an estimated 300 million people world-wide and the number of disability-adjusted life
years lost is estimated at 15million per year. The main goals of treatment for asthma include achieving and
maintaining control of symptoms, normal activity levels, minimal exacerbations, normal lung function and preventing
deaths from asthma. However, these goals are not widely achieved; people with asthma often tolerate unnecessary
symptoms, and management of the condition can often be suboptimal. Guided self-management for asthma as part of
systematic, planned care can lead to improvements in patient outcomes such as increases in knowledge, confidence to
manage asthma and improved quality of life, as well as reductions in hospitalizations, emergency room visits,
unscheduled visits to the doctor, and days off work.
Participants/ population
Adults (aged 16 or over) with a diagnosis of asthma as defined by authors of primary studies
Intervention(s), exposure(s)
We define “digital intervention” as any intervention delivered by digital technology. This includes, but is not limited
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to, web-based interventions on PC or mobile devices, apps on smart phones, and interventions delivered by SMS or
IVR (interactive voice recognition). Interventions should take information from users and provide tailored advice on
self-management. Some form of facilitated or supported access may be included.
Comparator(s)/ control
Usual care.
We will also compare other groups in studies where there are additional controls in addition to usual care.
Outcome(s)
Primary outcomes
Primary outcomes may include:.
• Measures of asthma control, Symptoms (e.g. diary card scores)
• Measures of asthma quality of life
• Exacerbations
• Restricted activities (e.g. days of work/school/disturbed nights)
• Lung function: e.g. spirometry & reversibility, peak expiratory f low
• Medication utilisation 
• Compliance with medication
• Health service utilisation (including scheduled/unscheduled, and primary/secondary
care)
• Biomarkers of airway inflammation (e.g. exhaled nitric oxide)
• Adverse events
Secondary outcomes
• Patient satisfaction
• Patient knowledge
• Adherence to monitoring tools
• Recruitment and retention rates
• Markers of self care (action plan use, inhaler technique for example)
• Data about economic benefits.
Data extraction, (selection and coding)
Studies that meet the inclusion criteria will then be screened in full by a minimum of two reviewers working
independently to extract the relevant population, intervention and outcome data as relates to the primary and
secondary outcomes above. This will be completed using data extraction forms on the Distiller software
(http://systematic-review.net/) based on established data extraction forms. Again any inter-reviewer disagreements
will be resolved by seeking consensus or decision by a third party
Risk of bias (quality) assessment
Risk of bias will be assessed in each of the included studies by the reviewers working independently. They will assess
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data bias as per the Cochrane collaboration’s tool for assessing bias. Areas of bias that will be assessed will include;
allocation concealment, method of generation of allocation sequence, how knowledge of the allocated intervention
was prevented during the study, whether incomplete outcome data was assessed, whether there was evidence of
selective outcome reporting and whether there were any other problems that put the study at high risk of bias.
Strategy for data synthesis
Data will be synthesised using Distiller software. Tests for heterogeneity and publication bias will be conducted. Meta-
regression will be performed to evaluate whether baseline factors may influence the significance and strength of the
effect size.
Analysis of subgroups or subsets
This will depend on the results found. The meta-analysis could be stratified by type of intervention; time period of
intervention; and/or study population.
Dissemination plans
It is intended to publish proctocol and final results of review and analysis in peer review journals.
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